Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a multi-center, randomized, double-blind, placebo controlled trial (GWPCARE4) (S21.001)
View Full Paper
Ask AI
Bookmark
Share
Abstract
Evaluate efficacy of CBD added to antiepileptic drug (AED) therapy for the treatment of seizures associated with LGS.
Discussion
No takes yet. Share an insight, caveat, or question.